Form 4 for ANRO Alto Neuroscience, Inc.

Accepted 2024-02-07 00:00:00 ET · period of report 2024-02-06 · accession 0001415889-24-002942 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-07	2024-02-06	ANRO	York Gwill	Dir	C - Cnv Deriv	—	+23.9K	23.9K	New	—
D	2024-02-07	2024-02-06	ANRO	York Gwill	Dir	C - Cnv Deriv	$0.00	-53.2K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-06	C	A	23,917	—	23,917	D	—	—	(F1) Each share of Series A Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and had no expiration date.
2	Derivative	Series A Preferred Stock	2024-02-06	C	D	53,196	$0.00	0	D	— · — to —	23,917 Common Stock	(F1) Each share of Series A Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and had no expiration date.